Dose-finding Study of MT-1303

Clinical trial NCT01742052 · COMPLETED

Trial details

NCT number: NCT01742052
Sponsor: Tanabe Pharma Corporation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsing-remitting Multiple Sclerosis

Start date: 2013-01-01
Primary completion: 2014-07-01
Enrollment: 415

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.